Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: LIBRETTO-001 trial

Selpercatinib (LOXO-292) shows durable activity in RET fusion-positive lung cancer

Presented By
Dr Alexander Drilon, Memorial Sloan Kettering Cancer Center, USA
Trial
LIBRETTO-001
Conference
WCLC 2019

8 November, 2019 19:01
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy